EASEPAL(SZ:002614)2022-12-07 09:44Group 1: Financial Performance - In Q3 2014, the company's operations grew by 26.98% compared to the same period last year, with OGAWA growing by 60.79% and COZZIA by 72.55% [1] - The revenue from self-owned brands accounted for 32% of total revenue [1] - The expected revenue weight of self-owned brands for the entire year of 2014 is projected to exceed 30% [2] Group 2: Future Development Strategy - The company aims to upgrade R&D and establish a "product + service" model as part of its health strategy [2] - Collaboration with Guangzhou Institute of Respiratory Diseases to create a health management platform for respiratory diseases, focusing on the health industry [2] - Establishment of a "Health Industry Research Institute" that integrates emerging technologies like IoT and mobile internet, targeting innovative "strategic products and platforms" in the health sector [2]